Phosphoproteomics of Primary Cells Reveals Druggable Kinase Signatures in Ovarian Cancer
Our understanding of the molecular determinants of cancer is still inadequate because of cancer heterogeneity. Here, using epithelial ovarian cancer (EOC) as a model system, we analyzed a minute amount of patient-derived epithelial cells from either healthy or cancerous tissues by single-shot mass-s...
Main Authors: | Chiara Francavilla, Michela Lupia, Kalliopi Tsafou, Alessandra Villa, Katarzyna Kowalczyk, Rosa Rakownikow Jersie-Christensen, Giovanni Bertalot, Stefano Confalonieri, Søren Brunak, Lars J. Jensen, Ugo Cavallaro, Jesper V. Olsen |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-03-01
|
Series: | Cell Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211124717303327 |
Similar Items
-
RNA Polymerase III Subunit Mutations in Genetic Diseases
by: Elisabeth Lata, et al.
Published: (2021-07-01) -
Novel mutations of the POLR3A gene caused POLR3-related leukodystrophy in a Chinese family: a case report
by: Shuiyan Wu, et al.
Published: (2019-08-01) -
Measuring pathway database coverage of the phosphoproteome
by: Hannah Huckstep, et al.
Published: (2021-05-01) -
Phosphoproteome Discovery in Human Biological Fluids
by: Francesco Giorgianni, et al.
Published: (2016-12-01) -
The RdoA-dependent Phosphoproteome Profile of Salmonella enterica
by: Roque, OLIVIA
Published: (2009)